Glaukos | search
Click here to view Glaukos news from 60+ newspapers.
Bookmark or Share- About Us - GlaukosFounded in 1998, Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
- Glaukos - Investor RelationsGlaukos Corporation One Glaukos Way Aliso Viejo, CA 92656. 949-481-0510 Send Email Fax: 949-367-9984
- Advancing the Treatment of Ophthalmic Diseases | GlaukosAt Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies that advance the existing standard of care, and enrich the lives and treatment alternatives for patients worldwide.
- Glaukos - Glaukos Announces FDA Approval of iDose®TR (travoprost ...Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos first developed Micro-Invasive Glaucoma Surgery (MIGS) as an alternative to the traditional glaucoma treatment paradigm ...
- GlaukosGlaukos Patient Services (GPS) is an individualized support program for patients with glaucoma.
More
